2 days ago
ABBV
AnalystsVamil DivanVamil Divan's Stock Forecasts
AnalystsVamil Divan
Analyst Ranking
Top 4%
#153 out of 4868 analysts
Average Return
+14.95%
Win Rate
55%86 out of 155
Risk vs Reward
Poor
Good
Vamil Divan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cabaletta Bio IncCABA | +702.34% | $1.28 | $10.27 | 2022-05-24 - 2023-05-24 | Strong Buy |
Cabaletta Bio IncCABA | +313.27% | $1.96 | $8.10 | 2022-03-17 - 2023-03-17 | Strong Buy |
Insmed IncINSM | +265.91% | $20.36 | $74.50 | 2023-07-25 - 2024-07-25 | Strong Buy |
Insmed IncINSM | +185.36% | $26.37 | $75.25 | 2023-09-04 - 2024-09-04 | Strong Buy |
Revance Therapeutics IncRVNC | +170.20% | $13.22 | $35.72 | 2022-05-11 - 2023-05-11 | Strong Buy |
Vamil Divan Analyst Color
Get additional color on Vamil Divan's coverage of popular stocks
2 months ago
ANIP
2 months ago
VERA
3 months ago
MRK
3 months ago
ABBV
6 months ago
JNJ
6 months ago
ABBV
6 months ago
VERA
7 months ago
TVTX
10 months ago
INSM
a year ago
VERA
a year ago
ABBV
a year ago
ANIP
a year ago
INSM
a year ago
PFE
2 years ago
INSM
2 years ago
ANIP
2 years ago
SAGE
2 years ago
ANIP
2 years ago
RVNC
2 years ago
ANIP
2 years ago
SCYX
2 years ago
JNJ
3 years ago
RVNC
3 years ago
KRTX
Vamil Divan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Abbvie IncABBV | 20 | Strong Buy | $216.00 | +10.71% | Maintains | 2 days ago |
Unicycive Therapeutics IncUNCY | 1 | Strong Buy | $6.00 | +820.25% | Initiates Coverage On | 10 days ago |
Merck & Co IncMRK | 7 | Strong Buy | $115.00 | +34.98% | Reiterates | 14 days ago |
Travere Therapeutics IncTVTX | 7 | Strong Buy | $47.00 | +125.85% | Reiterates | 17 days ago |
Ani Pharmaceuticals IncANIP | 10 | Strong Buy | $86.00 | +21.43% | Reiterates | 20 days ago |
Assembly Biosciences IncASMB | 1 | Strong Buy | $31.00 | +172.17% | Initiates Coverage On | a month ago |
Absci CorpABSI | 3 | Strong Buy | $10.00 | +225.73% | Reiterates | a month ago |
Vera Therapeutics IncVERA | 5 | Strong Buy | $61.00 | +161.02% | Maintains | 2 months ago |
Insmed IncINSM | 6 | Strong Buy | $101.00 | +40.28% | Reiterates | 2 months ago |
Pfizer IncPFE | 14 | Strong Buy | $33.00 | +35.19% | Reiterates | 3 months ago |
Johnson & JohnsonJNJ | 8 | Hold | $166.00 | +6.20% | Maintains | 3 months ago |
Revance Therapeutics IncRVNC | 6 | Hold | $3.10 | -15.07% | Maintains | 5 months ago |
Keros Therapeutics IncKROS | 2 | Strong Buy | $102.00 | +606.37% | Maintains | 5 months ago |
Prokidney CorpPROK | 1 | Strong Buy | $6.00 | +577.20% | Initiates Coverage On | 8 months ago |
Alpine Immune Sciences IncALPN | 1 | Strong Buy | $55.00 | N/A | Initiates Coverage On | a year ago |
Karuna Therapeutics IncKRTX | 7 | Hold | $330.00 | N/A | Downgrades | a year ago |
Sage Therapeutics IncSAGE | 7 | Hold | $20.00 | N/A | Maintains | 2 years ago |
Calliditas Therapeutics AbCALT | 2 | Hold | $18.00 | N/A | Maintains | 2 years ago |
Relmada Therapeutics IncRLMD | 2 | Strong Buy | $26.00 | N/A | Reiterates | 2 years ago |
Chinook Therapeutics IncKDNY | 3 | Hold | $40.00 | N/A | Downgrades | 2 years ago |
Scynexis IncSCYX | 2 | Strong Buy | $9.00 | N/A | Maintains | 2 years ago |
Aerovate Therapeutics IncAVTE | 1 | Strong Buy | $1,260.00 | N/A | Initiates Coverage On | 2 years ago |
Satsuma Pharmaceuticals IncSTSA | 5 | Hold | $2.00 | N/A | Downgrades | 2 years ago |
Acadia Pharmaceuticals IncACAD | 7 | Hold | $19.00 | N/A | Maintains | 3 years ago |
Neurocrine Biosciences IncNBIX | 5 | Hold | $98.00 | N/A | Maintains | 3 years ago |
Alkermes PLCALKS | 7 | Strong Buy | $34.00 | N/A | Maintains | 3 years ago |
Cabaletta Bio IncCABA | 3 | Strong Buy | $10.00 | N/A | Maintains | 3 years ago |
Axsome Therapeutics IncAXSM | 3 | Strong Buy | $49.00 | N/A | Maintains | 3 years ago |
Eli Lilly & CoLLY | 12 | Strong Buy | $356.00 | N/A | Maintains | 3 years ago |
Xeris Biopharma Holdings IncXERS | 1 | Strong Buy | $6.00 | N/A | Maintains | 3 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 9 | Strong Buy | $154.00 | N/A | Maintains | 3 years ago |
Evolus IncEOLS | 4 | Strong Buy | $15.00 | N/A | Upgrades | 4 years ago |
Allergan PLCAGN | 9 | Hold | $155.00 | N/A | Maintains | 6 years ago |
Teva Pharmaceutical Industries LtdTEVA | 10 | Hold | $20.00 | N/A | Maintains | 6 years ago |
Galapagos NvGLPG | 3 | Buy | N/A | N/A | Upgrades | 6 years ago |
Portola Pharmaceuticals IncPTLA | 6 | Hold | $30.00 | N/A | Maintains | 6 years ago |
Alder Biopharmaceuticals IncALDR | 2 | Hold | $17.00 | N/A | Maintains | 6 years ago |
Corvus Pharmaceuticals IncCRVS | 3 | Buy | $15.00 | N/A | Assumes | 7 years ago |
Aimmune Therapeutics IncAIMT | 3 | Buy | $40.00 | N/A | Maintains | 7 years ago |
Bristol Myers Squibb CoBMY | 2 | Hold | $61.00 | N/A | Maintains | 7 years ago |
Allena Pharmaceuticals IncALNAQ | 2 | Buy | $21.00 | N/A | Maintains | 7 years ago |
Esperion Therapeutics IncESPR | 2 | Buy | $103.00 | N/A | Initiates Coverage On | 7 years ago |
Myokardia IncMYOK | 1 | Buy | $55.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.